Monday 7/20 Insider Buying Report: NVA, KROS

At Nova Minerals, a filing with the SEC revealed that on Wednesday, Chief Executive Officer Christopher Gerteisen bought 2,007 shares of NVA, at a cost of $6.90 each, for a total investment of $13,848. Bargain hunters are able to bag NVA at a price even lower than Gerteisen did, with shares changing hands as low as $4.08 in trading on Monday which is 40.9% under Gerteisen's purchase price. Nova Minerals is trading down about 5% on the day Monday. This buy marks the first one filed by Gerteisen in the past twelve months.

And also on Wednesday, Jean Jacques Bienaime purchased $10,610 worth of Keros Therapeutics, purchasing 1,000 shares at a cost of $10.61 each. Before this latest buy, Bienaime purchased KROS at 3 other times during the past year, for a total investment of $32,470 at an average of $10.82 per share. Keros Therapeutics is trading up about 0.2% on the day Monday.

VIDEO: Monday 7/20 Insider Buying Report: NVA, KROS

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

This data feed is not available at this time.